深层脑部刺激器市场规模、份额、成长分析（按产品类型、应用、最终用户和地区）- 产业预测，2025 年至 2032 年

预计全球深部脑部刺激 (DBS) 设备市场规模在 2023 年将达到 15.4 亿美元，并从 2024 年的 16.8 亿美元增长到 2032 年的 34 亿美元，预测期内（2025-2032 年）的复合年增长率为 9.2%。

全球深部脑部刺激设备市场正在经历强劲成长，这得益于帕金森氏症和自发性震颤等神经系统疾病的发病率不断上升，从而增加了对有效治疗解决方案的需求。 DBS 技术的进步，包括使用寿命更长的可充电设备和改进的瞄准系统，提高了该程序的有效性和安全性。 DBS 作为一种可靠的治疗方法越来越受到认可，患者和医疗专业人士的认知度不断提高，也为市场扩张做出了巨大贡献。已开发地区优惠的报销政策和新兴市场不断增长的医疗保健投资进一步推动了製造商的成长机会。总体而言，这些因素的整合可能在未来几年内显着推动 DBS 设备市场的发展。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术分析
• 监管分析

深层脑部刺激器市场规模（依产品类型）

• 市场概况
• 单通道 DBS 设备
• 双通道DBS设备

深层脑部刺激器市场规模（依应用）

• 市场概况
• 癫痫
• 疼痛管理
• 自发性震颤
• 强迫性精神官能症(OCD)
• 帕金森氏症
• 忧郁症
• 肌张力不全症
• 其他的

深层脑部刺激器市场规模（依最终用户划分）

• 市场概况
• 医院
• 神经科诊所
• 门诊手术中心
• 研究中心
• 其他的

深层脑部刺激器市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Medtronic Plc.（USA）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Aleva Neurotherapeutics SA（Switzerland）
• Beijing PINS Medical Co., Ltd.（China）
• Brainsway Ltd.（USA）
• NeuroPace Inc.（USA）
• Functional Neuromodulation Ltd.（USA）
• NeuroSigma, Inc.（USA）
• Beijing Pinchi Medical Equipment Co., Ltd.（China）
• SceneRay Corporation Ltd.（China）
• Sapiens Steering Brain Stimulation（Netherlands）
• Renishaw plc（UK）
• Synapse Biomedical Inc.（USA）
• Deep Brain Innovations LLC（USA）
• Newronika SpA（Italy）
• Nexstim Plc（Finland）
• Neuronetics, Inc.（USA）
• Magstim Company Limited（UK）
• Bioinduction Ltd.（UK）

结论和建议

Global Deep Brain Stimulation Devices Market size was valued at USD 1.54 billion in 2023 and is poised to grow from USD 1.68 billion in 2024 to USD 3.4 billion by 2032, growing at a CAGR of 9.2% during the forecast period (2025-2032).

The global deep brain stimulation (DBS) device market is experiencing robust growth, driven by the rising incidence of neurological disorders such as Parkinson's disease and essential tremor, which has intensified the demand for effective treatment solutions. Advances in DBS technology, including longer-lasting rechargeable devices and improved targeting systems, have enhanced procedural efficacy and safety. Increased acceptance of DBS as a credible treatment, along with heightened awareness among patients and healthcare professionals, contributes significantly to market expansion. Favorable reimbursement policies in developed regions and escalating healthcare investments in emerging markets are further propelling growth opportunities for manufacturers. Overall, the convergence of these factors positions the DBS device market for substantial advancement in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Deep Brain Stimulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Deep Brain Stimulation Devices Market Segments Analysis

Global Deep Brain Stimulation Devices Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Single-channel DBS Devices and Dual-channel DBS Devices. Based on Application, the market is segmented into Epilepsy, Pain Management, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinson's Disease, Depression, Dystonia and Others. Based on End User, the market is segmented into Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Deep Brain Stimulation Devices Market

The Global Deep Brain Stimulation Devices market is primarily driven by innovations in technology that have markedly enhanced patient outcomes and broadened the array of conditions that can be effectively treated. Key advancements include the creation of highly accurate targeting systems and refined stimulation parameters, alongside the incorporation of sophisticated features like closed-loop systems and adaptive algorithms. These technological improvements facilitate personalized treatment regimens, optimize symptom management, and lessen potential side effects, thereby strengthening the overall efficacy and safety of deep brain stimulation therapy. As a result, the market is experiencing robust growth fueled by these transformative developments.

Restraints in the Global Deep Brain Stimulation Devices Market

The global deep brain stimulation devices market faces significant restraints primarily due to the complexity of these devices, which necessitate precise implantation surgeries conducted by highly skilled neurosurgeons. The overall expenses associated with these devices-encompassing the hardware, leads, and programming systems-can be quite high. Furthermore, the costs associated with the surgical procedure increase as they require specialized equipment, operating room facilities, and extensive post-operative care. This high financial burden presents a barrier to affordability and accessibility, particularly in regions where healthcare resources are scarce or insurance coverage is insufficient, limiting the market's potential growth.

Market Trends of the Global Deep Brain Stimulation Devices Market

The Global Deep Brain Stimulation (DBS) Devices market is witnessing significant growth, largely fueled by the rising prevalence of neurological disorders, particularly among the aging population. Conditions such as Parkinson's disease, essential tremor, and dystonia are becoming increasingly common due to factors like chronic disease proliferation and exposure to environmental toxins. As awareness about DBS as a highly effective treatment option spreads, there is a marked increase in demand for these devices. This trend underscores a shifting focus towards innovative surgical interventions in neurology, positioning the DBS market for robust expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis

Global Deep Brain Stimulation Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Single-channel DBS Devices
• Dual-channel DBS Devices

Global Deep Brain Stimulation Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Epilepsy
• Pain Management
• Essential Tremor
• Obsessive Compulsive Disorder (OCD)
• Parkinson's Disease
• Depression
• Dystonia
• Others

Global Deep Brain Stimulation Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Neurology Clinics
• Ambulatory Surgical Centers
• Research Centers
• Others

Global Deep Brain Stimulation Devices Market Size & CAGR (2025-2032)

• North America (Product Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic Plc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aleva Neurotherapeutics S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing PINS Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brainsway Ltd. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Functional Neuromodulation Ltd. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroSigma, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing Pinchi Medical Equipment Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SceneRay Corporation Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sapiens Steering Brain Stimulation (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Renishaw plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Deep Brain Innovations LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Newronika S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nexstim Plc (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuronetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Magstim Company Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioinduction Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations